Fiona Smith-Laittan

Fiona Smith-Laittan has been appointed Chair of Cambridge Global Health Partnerships

Fiona Smith-Laittan, Vice President of Global Health Strategy and Partnerships at GlaxoSmithKline (GSK), has been appointed Chair of Cambridge Global Health Partnerships (CGHP).

Fiona, who has led GSK’s Global Health Strategy and Partnerships team since 2019, said: “CGHP’s purpose, strategy and activity is aligned to what I care about most, in an area where I bring significant experience, insights and a strong network.

“The global health funding landscape is facing significant challenges, with the multiplicative effects of poverty, conflict and climate change, exacerbated by fractured geopolitics and limited global resources. I am passionate about the need for ambitious cross-functional partnerships to drive sustainable impact in global health, which is fundamental to what CGHP stands for,” she added.

At GSK, Fiona’s focus is on positively impacting the health of people in lower-income countries through research, access and strengthened health systems. She has established the organisation’s 5-10-year Global Health strategy, prioritised investment of up to £100m a year on TB, malaria and antimicrobial resistance, and is managing significant long-term programmes with leading global health institutions.

A proud graduate of the University of Cambridge (Natural Sciences – Neuroscience, Emmanuel College), Fiona is passionate about the role of science and scientists in driving societal change, and the important contribution of academic excellence and international development to the UK’s position on the world stage.